Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

The board of Quest Diagnostics Incorporated ( NYSE:DGX ) has announced that it will be paying its dividend of $0.80 ...

Investing.com -- Quest Diagnostics (NYSE: NYSE: DGX ), a prominent player in diagnostic information services, announced today ...

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Quest Diagnostics (DGX – Research Report), ...

Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.

This was the stock's third consecutive day of gains.

The collaboration between Quest and Google Cloud is the latest example of the use of AI agents in healthcare to automate ...

This was the stock's second consecutive day of losses.

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.